Table 2. Phenotypic characterization of immunomagnetically isolated stem/progenitor cell populations of UCB.
Antigen | Cells expressed stem/progenitor surface markers among human UCB-derived | ||
lineage-negative cells | CD34+ cells | CD133+ cells | |
(mean ± SD) | (mean ± SD) | (mean ± SD) | |
CD34+ | 12.1%±7.2% | 91.2%±4.8% | 60.3%±9.2% |
CD133+ | 12.3%±8.2% | 72.1%±12.6% | 94.2%±5.1% |
CD34+/CD133+ | 8.5%±5.0% | 69.5%±11.3% | 55.43%±13.4% |
CXCR4+ | 89.9%±3.3% | 74.9%±13.1% | 50.4%±11.0% |
CD144+ | 3.1%±1.6% | 5.5%±1.8% | 4.9%±2.1% |
Endotelial progenitor cells (CD34+/CD133+/CD144+) | 1.7%±1.1% | 3.8%±2.1% | 3.3%±1.4% |
Mesenchymal stem cells (CD105+/CD73+/CD90+/CD45−/CD34−/CD11b−/CD19−/HLA-DR−) | 0.0084%±0.0108% | — | — |